TAP Advisor
FDA
Laura Gottschalk in an Advisor with th Total Product Life Cycle Advisory Program (TAP) Pilot, a new program in CDRH to help spur faster development of high-quality, safe, effective, and innovative medical devices that are critical to meeting public health needs. She started her FDA career in 2017 in CDRH as a Lead Reviewer in the gastrointestinal and hepatobiliary devices group before moving to CBER for three years where she served as the Regulatory Project Manager on the Pfizer COMIRNATY BLA and EUA during the COVID-19 pandemic. Laura holds a PhD in Cellular and Molecular Medicine from The Johns Hopkins School of Medicine and has additional non-regulatory experience from working across different offices within HHS as well completing a post-doctoral fellowship with a health policy non-profit.
Thursday, September 19, 2024
4:30 PM - 5:30 PM PDT